Inogen appoints stanislav glezer as chief technology officer

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), (“inogen” or “the company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that stanislav glezer, md has been appointed to the role of chief technology officer responsible for r&d and engineering, medical affairs, and regulatory affairs. mr. glezer will remain an executive vice president of the company. dr. glezer joined inogen in june 2021 as executive vice
INGN Ratings Summary
INGN Quant Ranking